Aug. 01, 2011
NewsCompany News

Merck Millipore Completed Acquisition of Biotest AG

Merck Millipore, the Life Science division of Merck KGaA, announced that it has completed the acquisition of the microbiology business of Biotest AG, Dreieich, Germany. All relevant authorities approved the sale of Biotest´s woldwide Microbiological Monitoring business activities, which consist of the product portfolio of Hycon (hygiene monitoring based in Dreieich) and the product portfolio of heipha Dr. Müller GmbH (microbiological culture media and microbiological test systems, based in Eppelheim, Germany) to Merck. Merck and Biotest closed the transaction, which was agreed upon in March 2011.

The acquired businesses will add to Merck Millipore's existing dehydrated cell-culture media and testing systems, the so called "ready-to-use" culture media and instruments. The products are primarily used in the pharmaceutical, food & beverage, and personal-care industries.

The acquisition allows the Merck Millipore division to complement its product portfolio in the attractive growth segment industrial microbiology for contamination detection.

The acquired activities will be integrated into Merck Millipore's Lab Solutions business unit.

Contact

Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.